These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 9620107)

  • 1. Treatment of septic shock with immunotherapy.
    Smith AL
    Pharmacotherapy; 1998; 18(3):565-80. PubMed ID: 9620107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunotherapy in sepsis syndrome].
    Schellekens JF; van Deventer SJ
    Ned Tijdschr Geneeskd; 1992 May; 136(22):1050-4. PubMed ID: 1603159
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunotherapy of sepsis and septic shock].
    Ivanović D; Gjurasin M; Gasparović V; Radonić R; Kvarantan M; Merkler M
    Lijec Vjesn; 1995 Jun; 117 Suppl 2():8-11. PubMed ID: 8649167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The current management of septic shock.
    Russel JA
    Minerva Med; 2008 Oct; 99(5):431-58. PubMed ID: 18971911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapies for sepsis. Emerging therapies for sepsis and septic shock.
    Abraham E
    West J Med; 1997 Mar; 166(3):195-200. PubMed ID: 9143195
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical trials of immunomodulatory therapies in severe sepsis and septic shock.
    Vincent JL; Sun Q; Dubois MJ
    Clin Infect Dis; 2002 Apr; 34(8):1084-93. PubMed ID: 11914997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinically-oriented therapies in sepsis: a review.
    Dubois MJ; Vincent JL
    J Endotoxin Res; 2000; 6(6):463-9. PubMed ID: 11521072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cytokines and septic shock. New perspectives on its treatment].
    Zamora Madaria E
    An Med Interna; 1993 Dec; 10(12):573-5. PubMed ID: 8049320
    [No Abstract]   [Full Text] [Related]  

  • 9. Optimum treatment of severe sepsis and septic shock: evidence in support of the recommendations.
    Balk RA
    Dis Mon; 2004 Apr; 50(4):168-213. PubMed ID: 15133467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiendotoxin therapies for septic shock.
    Corriveau CC; Danner RL
    Infect Agents Dis; 1993 Feb; 2(1):44-52. PubMed ID: 8162353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-activating factor antagonists: scientific background and possible clinical applications.
    Koltai M; Guinot P; Hosford D; Braquet PG
    Adv Pharmacol; 1994; 28():81-167. PubMed ID: 8080821
    [No Abstract]   [Full Text] [Related]  

  • 12. [Monoclonal antibodies in the treatment of sepsis and septic shock].
    Torrabadella de Reynoso P; Salgado Remigio A; Peracaula Picart R
    Med Clin (Barc); 1992 Dec; 99(20):784-92. PubMed ID: 1460952
    [No Abstract]   [Full Text] [Related]  

  • 13. [Septic shock].
    Grinev MV; Bagnenko SF; Kulibaba DM; Gromov MI
    Vestn Khir Im I I Grek; 2004; 163(2):12-7. PubMed ID: 15199763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of septic shock and implications for therapy.
    Barron RL
    Clin Pharm; 1993 Nov; 12(11):829-45. PubMed ID: 8161370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New therapies in sepsis.
    Vincent JL
    Chest; 1997 Dec; 112(6 Suppl):330S-338S. PubMed ID: 9400898
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of septic shock with antibodies to tumour necrosis factor.
    Cohen J; Exley AR
    Schweiz Med Wochenschr; 1993 Mar; 123(11):492-6. PubMed ID: 8475356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis.
    Laupland KB; Kirkpatrick AW; Delaney A
    Crit Care Med; 2007 Dec; 35(12):2686-92. PubMed ID: 18074465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Why is immune therapy in sepsis unsuccessful?].
    van Deventer SJ
    Ned Tijdschr Geneeskd; 1995 Mar; 139(11):548-9. PubMed ID: 7700389
    [No Abstract]   [Full Text] [Related]  

  • 19. Lethal outcome caused by Porphyromonas gingivalis A7436 in a mouse chamber model is associated with elevated titers of host serum interferon-gamma.
    Huang JH; Lin YY; Lai YY; Hu SW
    Oral Microbiol Immunol; 2006 Apr; 21(2):100-6. PubMed ID: 16476019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of severe sepsis and septic shock--are antibiotics the only remedy to treat infections?].
    Złotorowicz M
    Przegl Epidemiol; 2001; 55 Suppl 3():81-4. PubMed ID: 11984966
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.